Moran Wealth Management LLC lifted its stake in Chemed Co. (NYSE:CHE – Free Report) by 0.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,043 shares of the company’s stock after purchasing an additional 20 shares during the period. Moran Wealth Management LLC owned 0.23% of Chemed worth $18,036,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. Farther Finance Advisors LLC lifted its position in shares of Chemed by 2,314.3% in the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock worth $203,000 after buying an additional 324 shares in the last quarter. QRG Capital Management Inc. grew its stake in shares of Chemed by 5.1% during the third quarter. QRG Capital Management Inc. now owns 1,368 shares of the company’s stock valued at $822,000 after buying an additional 66 shares during the last quarter. Impax Asset Management Group plc increased its stake in Chemed by 4.7% in the third quarter. Impax Asset Management Group plc now owns 332,757 shares of the company’s stock worth $199,977,000 after purchasing an additional 14,814 shares during the period. Legacy Capital Wealth Partners LLC increased its stake in Chemed by 87.8% in the 3rd quarter. Legacy Capital Wealth Partners LLC now owns 1,979 shares of the company’s stock worth $1,189,000 after buying an additional 925 shares during the period. Finally, TimesSquare Capital Management LLC grew its stake in Chemed by 7.5% in the third quarter. TimesSquare Capital Management LLC now owns 167,135 shares of the company’s stock worth $100,443,000 after purchasing an additional 11,595 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.
Chemed Trading Up 0.3 %
Shares of NYSE:CHE opened at $595.86 on Monday. The company has a market capitalization of $8.72 billion, a PE ratio of 30.11, a PEG ratio of 2.15 and a beta of 0.43. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $654.62. The business has a 50 day moving average of $553.87 and a two-hundred day moving average of $563.91.
Chemed Announces Dividend
Insider Activity at Chemed
In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the transaction, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. The trade was a 1.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Brian C. Judkins bought 145 shares of Chemed stock in a transaction dated Monday, December 30th. The stock was purchased at an average cost of $519.50 per share, with a total value of $75,327.50. Following the completion of the acquisition, the vice president now directly owns 1,678 shares in the company, valued at approximately $871,721. The trade was a 9.46 % increase in their position. The disclosure for this purchase can be found here. 3.32% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Separately, StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research report on Friday.
Get Our Latest Analysis on Chemed
Chemed Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Further Reading
- Five stocks we like better than Chemed
- Short Selling – The Pros and Cons
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- What is a SEC Filing?
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.